Kidney Cancer


November 6th, 2009 - November 6th, 2012
1.00 AMA PRA Category 1 Credit Hours

Description

The American Urological Association foundation states that with timely diagnosis and treatment, kidney cancer can be cured. If found early, the survival rate for patients with kidney cancer ranges from 79 to 100 percent.
The webcast is no longer available.
Post-Test taking for this webcast is no longer available.

Dates and Times

End Date: 11/6/2012

Objectives

Upon completion of this educational activity, the participant should be able to: 1.) Explain the incidence and etiology of renal cell carcinoma. 2.) Review the systemic approach in diagnosing and staging renal cell carcinoma. 3.) Discuss current surgical management of small renal masses. 4.) Describe how new targeted therapies are the standard of care for metastatic renal cancer.

Webcasts Files

File Link

PDF of Slides

Download

Accreditation

The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians

The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim credit commensurate with the extent of their participation in the activity.